Theodora Kunovac Kallak
Researcher at Institutionen för kvinnors och barns hälsa; Reproduktiv hälsa
- E-mail:
- theodora.kunovac_kallak@uu.se
- Visiting address:
- Rudbeckslaboratoriet Hus R3 plan 1
Dag Hammarskjölds väg 20
SE-752 37 Uppsala
Sweden - Postal address:
- Akademiska sjukhuset
SE-751 85 UPPSALA
Sweden
Associate senior lecturer/Assistant Professor at Institutionen för kvinnors och barns hälsa; Reproduktiv hälsa
- E-mail:
- theodora.kunovac_kallak@uu.se
- Visiting address:
- Rudbeckslaboratoriet Hus R3 plan 1
Dag Hammarskjölds väg 20
SE-752 37 Uppsala
Sweden - Postal address:
- Akademiska sjukhuset
SE-751 85 Uppsala
Sweden
More information is available to staff who log in.
Short presentation
I completed my PhD in medical sciences at Uppsala University in 2015. I am currently working as an associate senior lecturer at the Department of Women’s and Children’s Health, and I am one assistant director of the Centre for Reproductive Biology in Uppsala. During 2022 I am also the chair of Junior Faculty.
My research activities cover genitourinary symptoms of menopause, infertility, gynecological cancers, maternal health during pregnancy and the effect of the future health of the offspring.
Keywords
- infertility
- obesity
- pregnancy
- urogenital discomforts
Publications
Recent publications
- Differential gene expression in two consecutive pregnancies between same sex siblings and implications on maternal constraint (2024)
- Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression (2023)
- Study protocol (2023)
- Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses (2023)
- Maternal early mid-pregnancy adiponectin in relation to infant birth weight and the likelihood of being born large-for-gestational-age. (2023)
All publications
Articles
- Differential gene expression in two consecutive pregnancies between same sex siblings and implications on maternal constraint (2024)
- Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression (2023)
- Study protocol (2023)
- Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses (2023)
- Maternal early mid-pregnancy adiponectin in relation to infant birth weight and the likelihood of being born large-for-gestational-age. (2023)
- Identification of phthalate mixture exposure targets in the human and mouse ovary in vitro (2023)
- Cohort profile (2023)
- Maternal prenatal depressive symptoms and toddler behavior (2022)
- Pregnancy-related hormones and COMT genotype (2021)
- DNA methylation in cord blood in association with prenatal depressive symptoms (2021)
- Physical and Sedentary Activities in Association with Reproductive Outcomes among Couples Seeking Infertility Treatment (2021)
- Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels (2021)
- Polycystic ovary syndrome and risk of stillbirth (2021)
- Polycystic ovary syndrome and extremely preterm birth (2021)
- Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment. (2020)
- Maternal perinatal depressive symptoms trajectories and impact on toddler behavior (2020)
- Second Trimester Maternal Leptin Levels Are Associated with Body Mass Index and Gestational Weight Gain but not Birth Weight of the Infant (2020)
- Cohort profile (2019)
- The effect of antenatal depression and antidepressant treatment on placental tissue (2019)
- Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels (2019)
- Vasoactive intestinal peptide is upregulated in women with endometriosis and chronic pelvic pain (2018)
- Antenatal Depression and Placental Function (2018)
- Seasonal patterns in self-reported peripartum depressive symptoms (2017)
- Oxytocin stimulates cell proliferation in vaginal cell line Vk2E6E7. (2017)
- Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain (2017)
- Vaginal gene expression during treatment with aromatase inhibitors (2015)
- Folic acid supplementation and methylenetetrahydrofolate reductase (MTHFR)gene variations in relation to IVF pregnancy outcome (2015)
- Physical activity, fatness, educational level and snuff consumption as determinants of semen quality (2015)
- Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients (2014)
- Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer (2013)
- Treatment with aromatase inhibitor acts indirectly through the estrogen receptor pathway causing decreased junction plakoglobin mRNA expression and vaginal atrophy (2013)
- Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors (2013)
- Steroid hormone receptor expression, proliferative activity and microvessel density in the endometrium of women with polycystic ovary syndrome (2012)
- Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients (2012)
- Variation in Hyaluronan-Binding Protein 2 (HABP2) Promoter Region is Associated With Unexplained Female Infertility (2011)
- Tissue Factor and Tissue Factor Pathway Inhibitors TFPI and TFPI2 in Human Secretory Endometrium - Possible Link to Female Infertility (2011)
- Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer (2011)
- Low calcitonin receptor like receptor expression in endometrial vessels from women with unexplained infertility. (2011)
- The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study
- Primary Term Trophoblasts Release NT-proBNP
- Estrogenic regulation of aquaporin 3 in vaginal mucosa
Books
